Skip to main content
Erschienen in: Wiener klinische Wochenschrift 13-14/2013

01.07.2013 | original article

Primary care of patients with high cardiovascular risk

Blood pressure, lipid and diabetic target levels and their achievement in Hungary

verfasst von: Endre Szigethy, MSc, Zoltán Jancsó, Csaba Móczár, István Ilyés, Eszter Kovács, László Róbert Kolozsvári, Imre Rurik, PhD, MSc

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 13-14/2013

Einloggen, um Zugang zu erhalten

Summary

Cardiovascular diseases are responsible for the majority of premature deaths in Hungary as well. Most of them could be prevented with healthy lifestyle of patients and adequate drug prescription of primary care physicians. Earlier European surveys found wide differences between the practices and achievements of different countries in this field.
The study was based on and designed according to the framework of previous European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) studies and aimed presenting Hungarian results and comparing with the achievements of other countries and previous Hungarian surveys. Among rural and urban settings, 679 patients under continuous care (236 diabetics, 218 with dyslipidaemia, and 225 with hypertension) were consecutively selected by 20 experienced general practitioners. The mean age of patients was 60.3 years (men) and 64.0 years (women).
Among diabetics, less than 7 % of glycated hemoglobin (HbA1c) values were found in 42.5 % patients, while only 11.4 % patients had fasting plasma sugar less than 6.0 mmol/L. Of the patients treated for dyslipidaemia, the target level of triglyceride was reached by 40.6 %, recommended total cholesterol by 14.2 % and the HDL-cholesterol by 71.8 %. The therapeutic control of total and HDL-cholesterol was better in men, although women had better triglyceride values.
The achievement among patients with hypertension was 42.0 %. Significantly higher blood pressure was measured by patients who were treated with not recommended combinations of antihypertensive medication.
A remarkable improvement could be observed in Hungary in the field of secondary prevention. It was greater among patients with hypertension and dyslipidaemia and smaller in diabetes care. Compared to the results of published European surveys, Hungary occupies a good position, but further improvement is still required.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Graham I, Atar D, Borch-Johnsen K, Burell G, Citkova R. European guidelines on cardiovascular disease prevention in clinical practice: fourth join task force of European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14(Suppl 2) S1–S113. Graham I, Atar D, Borch-Johnsen K, Burell G, Citkova R. European guidelines on cardiovascular disease prevention in clinical practice: fourth join task force of European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14(Suppl 2) S1–S113.
2.
Zurück zum Zitat Allender S, Scharbotough P, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A. European cardiovascular disease statistics: 2008 edition. London:British Heart Foundation; 2008. Allender S, Scharbotough P, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A. European cardiovascular disease statistics: 2008 edition. London:British Heart Foundation; 2008.
3.
Zurück zum Zitat Lopez A, Mathers CD, Ezzati M, Jamison D, Murray C. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–57.PubMedCrossRef Lopez A, Mathers CD, Ezzati M, Jamison D, Murray C. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–57.PubMedCrossRef
4.
Zurück zum Zitat Józan P. Decreasing cardiovascular mortality, mending life expectancy, beginnings of a new epidemiological era in Hungary. (in Hungarian) IME. 2009;4:21–5. Józan P. Decreasing cardiovascular mortality, mending life expectancy, beginnings of a new epidemiological era in Hungary. (in Hungarian) IME. 2009;4:21–5.
6.
Zurück zum Zitat Szigethy E, Széles G, Horváth A, Hidvégi T, Jermendy G, Paragh G, Blaskó G, Ádány R, Vokó Z. Epidemiology of the metabolic syndrome in Hungary. Public Health. 2012;126:143–9.PubMedCrossRef Szigethy E, Széles G, Horváth A, Hidvégi T, Jermendy G, Paragh G, Blaskó G, Ádány R, Vokó Z. Epidemiology of the metabolic syndrome in Hungary. Public Health. 2012;126:143–9.PubMedCrossRef
7.
Zurück zum Zitat Hummers-Pradier E, Beyer M, Chevallier P, Eilat-Tsanani S, Lionis C, Peremans L, Petek D, Rurik I, Soler JK, Stoffers HEJH, Topsever P, Ungan M, van Royen P. Research Agenda for General Practice/Family Medicine and Primary health care in Europe. European General Practice Research Network. Maastricht, 2009. Hummers-Pradier E, Beyer M, Chevallier P, Eilat-Tsanani S, Lionis C, Peremans L, Petek D, Rurik I, Soler JK, Stoffers HEJH, Topsever P, Ungan M, van Royen P. Research Agenda for General Practice/Family Medicine and Primary health care in Europe. European General Practice Research Network. Maastricht, 2009.
8.
Zurück zum Zitat Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U. The EUROASPIRE Study Group. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil. 2010;17:530 (http://cpr.sagepub.com/content/17/5/530). Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U. The EUROASPIRE Study Group. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil. 2010;17:530 (http://​cpr.​sagepub.​com/​content/​17/​5/​530).
9.
Zurück zum Zitat EUROASPIRE Study group. EUROASPIRE. A European Society of cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J. 1997;18:1569–82. EUROASPIRE Study group. EUROASPIRE. A European Society of cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J. 1997;18:1569–82.
10.
Zurück zum Zitat Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. On behalf of EUROASPIRE Study Group. Cardiovascular prevention guidelines- the clinical reality: a comparison of EUROASPIRE I, II and III surveys in 8 European countries. Lancet. 2009;372:29–40. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. On behalf of EUROASPIRE Study Group. Cardiovascular prevention guidelines- the clinical reality: a comparison of EUROASPIRE I, II and III surveys in 8 European countries. Lancet. 2009;372:29–40.
11.
Zurück zum Zitat Hungarian Society for Hypertension. The guidelines of treatment and care for hypertensive patients. (ed. Kiss I.) (in Hungarian). Hypertens Nephrol. 2009;13(S2):81–168. Hungarian Society for Hypertension. The guidelines of treatment and care for hypertensive patients. (ed. Kiss I.) (in Hungarian). Hypertens Nephrol. 2009;13(S2):81–168.
12.
Zurück zum Zitat Hungarian Diabetes Society. Diagnoses, treatment and care of diabetic patients. Guideline. (ed. Jermendy G.) (in Hungarian) Diabetologia Hungarica. 2011; 19(Suppl 1):5–72. Hungarian Diabetes Society. Diagnoses, treatment and care of diabetic patients. Guideline. (ed. Jermendy G.) (in Hungarian) Diabetologia Hungarica. 2011; 19(Suppl 1):5–72.
13.
Zurück zum Zitat The 4th Hungarian Cardiovascular Consensus Conference. Recommendation for the risk evaluation, prevention and therapy of atherosclerotic cardiovascular diseases. (in Hungarian) Metabolizmus. 2009; 3:127. The 4th Hungarian Cardiovascular Consensus Conference. Recommendation for the risk evaluation, prevention and therapy of atherosclerotic cardiovascular diseases. (in Hungarian) Metabolizmus. 2009; 3:127.
14.
Zurück zum Zitat Paragh G, Pados G, Reiber I, Márk L, Czuriga I, Kiss Z. Why are we today for reaching the 10 % target? (in Hungarian). Cardiologica Hungarica. 2011;41:287–90. Paragh G, Pados G, Reiber I, Márk L, Czuriga I, Kiss Z. Why are we today for reaching the 10 % target? (in Hungarian). Cardiologica Hungarica. 2011;41:287–90.
15.
Zurück zum Zitat Paragh G, Márk L, Zámolyi K, Pados G, Ofner P. Lipid-modifying therapy and attainment of cholesterol goals in Hungary. The Return on Expenditure Achieved for Lipid Therapy (REALITY) Study. Clin Drug Invest. 2007;27:647–60.CrossRef Paragh G, Márk L, Zámolyi K, Pados G, Ofner P. Lipid-modifying therapy and attainment of cholesterol goals in Hungary. The Return on Expenditure Achieved for Lipid Therapy (REALITY) Study. Clin Drug Invest. 2007;27:647–60.CrossRef
16.
Zurück zum Zitat Márk L, Zámolyi K, Pados G, Paragh G, Ofner P. Achieving the target lipid levels in Hungary, 2004. Orv Hetil. 2005;146:147–52. (in Hungarian) Márk L, Zámolyi K, Pados G, Paragh G, Ofner P. Achieving the target lipid levels in Hungary, 2004. Orv Hetil. 2005;146:147–52. (in Hungarian)
17.
Zurück zum Zitat Rurik I, Killik M, Székely A. Experiences of family physicians participating in the first Hungarian government financed prevention program. (in Hungarian). Orv Hetil. 2006;147: 2507–13.PubMed Rurik I, Killik M, Székely A. Experiences of family physicians participating in the first Hungarian government financed prevention program. (in Hungarian). Orv Hetil. 2006;147: 2507–13.PubMed
18.
Zurück zum Zitat Ilyés I, Jancsó Z, Kovács E, Márton H, Simay A. Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care. (in Hungarian). Orv Hetil. 2005;146:2581–8.PubMed Ilyés I, Jancsó Z, Kovács E, Márton H, Simay A. Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care. (in Hungarian). Orv Hetil. 2005;146:2581–8.PubMed
19.
Zurück zum Zitat Jancsó Z, Varga Z, Simay A, Ilyés I. Continuing care of patients with cardiovascular risk in general practice: patients with dyslipidaemia and their care. (in Hungarian). Orv Hetil. 2005;146:2629–33.PubMed Jancsó Z, Varga Z, Simay A, Ilyés I. Continuing care of patients with cardiovascular risk in general practice: patients with dyslipidaemia and their care. (in Hungarian). Orv Hetil. 2005;146:2629–33.PubMed
20.
Zurück zum Zitat Jancsó Z, Márton H, Simay A, Újhelyi I, Ilyés I. Continuing care of patients with cardiovascular risk in general practice: patients with hypertension and their care. (in Hungarian). Orv Hetil. 2006;147:339–44.PubMed Jancsó Z, Márton H, Simay A, Újhelyi I, Ilyés I. Continuing care of patients with cardiovascular risk in general practice: patients with hypertension and their care. (in Hungarian). Orv Hetil. 2006;147:339–44.PubMed
21.
Zurück zum Zitat Jermendy G, Nádas J, Szigethy E, Széles G, Nagy A, Hàdvégi T, Paragh G, Ádány R. Prevalence rate of diabetes mellitus and impaired fasting glycemia in Hungary: cross-sectional study on nationally representative sample of people aged 20–69 years. Croat Med J. 2010;51:151–6.PubMedCrossRef Jermendy G, Nádas J, Szigethy E, Széles G, Nagy A, Hàdvégi T, Paragh G, Ádány R. Prevalence rate of diabetes mellitus and impaired fasting glycemia in Hungary: cross-sectional study on nationally representative sample of people aged 20–69 years. Croat Med J. 2010;51:151–6.PubMedCrossRef
22.
Zurück zum Zitat Vajó Z, Ács N, Tóth K, Dinya E, Paragh G, Császár A. Cardiovascular risk status and primary prevention in postmenopausal women: the MENOCARD study. Wien Klin Wochenschr. 2009;121:202–8.PubMedCrossRef Vajó Z, Ács N, Tóth K, Dinya E, Paragh G, Császár A. Cardiovascular risk status and primary prevention in postmenopausal women: the MENOCARD study. Wien Klin Wochenschr. 2009;121:202–8.PubMedCrossRef
23.
Zurück zum Zitat Pados G, Karádi I, Paragh G, Halmy L, Jermendy G, Zámolyi K, Kiss I. New features in the recommendations of the Second Hungarian Therapeutic Consensus Conference. (in Hungarian) Orv Hetil. 2006;147:1299–306. Pados G, Karádi I, Paragh G, Halmy L, Jermendy G, Zámolyi K, Kiss I. New features in the recommendations of the Second Hungarian Therapeutic Consensus Conference. (in Hungarian) Orv Hetil. 2006;147:1299–306.
24.
Zurück zum Zitat Barkai L, Halmos T, Hidvégi T, Jermendy G, Korányi L, Madácsy L, Pados G, Winkler G, Hungarian Diabetes Society, Metabolism Work Group. [The metabolic syndrome-clinical significance in 2011. Position statement of the Hungarian Diabetes Society, Metabolism Work Group]. Orv Hetil. 2011;152:1450–8. (Hungarian). Barkai L, Halmos T, Hidvégi T, Jermendy G, Korányi L, Madácsy L, Pados G, Winkler G, Hungarian Diabetes Society, Metabolism Work Group. [The metabolic syndrome-clinical significance in 2011. Position statement of the Hungarian Diabetes Society, Metabolism Work Group]. Orv Hetil. 2011;152:1450–8. (Hungarian).
25.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma. without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMed Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma. without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMed
26.
Zurück zum Zitat Meier M, Hummel M. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies. Vasc Health Risk Manag. 2009;5:859–71.PubMedCrossRef Meier M, Hummel M. Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies. Vasc Health Risk Manag. 2009;5:859–71.PubMedCrossRef
27.
Zurück zum Zitat Ott P, Benke I, Stelzer J, Kahler C, Hanefeld M. [“Diabetes in Germany” (DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice]. (in German). Dtsch Med Wochenschr. 2009;134:291–7.PubMedCrossRef Ott P, Benke I, Stelzer J, Kahler C, Hanefeld M. [“Diabetes in Germany” (DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice]. (in German). Dtsch Med Wochenschr. 2009;134:291–7.PubMedCrossRef
28.
Zurück zum Zitat Skara Mehner A, Lindblad U, Ráastam L, Bostrám KB. Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men. Eur J Clin Pharmacol. 2008;64:815–20.CrossRef Skara Mehner A, Lindblad U, Ráastam L, Bostrám KB. Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men. Eur J Clin Pharmacol. 2008;64:815–20.CrossRef
29.
Zurück zum Zitat Hartz I, Eggen AE, Grimsgaard S, Skjold F, Njálstad I. Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based stuffy. The Tromso study 2001. Eur J Clin Pharmacol. 2004;60:643–9.PubMedCrossRef Hartz I, Eggen AE, Grimsgaard S, Skjold F, Njálstad I. Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based stuffy. The Tromso study 2001. Eur J Clin Pharmacol. 2004;60:643–9.PubMedCrossRef
30.
Zurück zum Zitat Ducher M, Juillard L, Leutenegger E, Fauvel JP. Major cardiovascular risk factors are not taken into account by physicians when targeting blood pressure values for uncontrolled hypertensive patients. Am J Hypertens. 2008;21:1264–8.PubMedCrossRef Ducher M, Juillard L, Leutenegger E, Fauvel JP. Major cardiovascular risk factors are not taken into account by physicians when targeting blood pressure values for uncontrolled hypertensive patients. Am J Hypertens. 2008;21:1264–8.PubMedCrossRef
31.
Zurück zum Zitat Páll D, Kiss I, Katona É. Importance of ambulatory blood pressure monitoring. Kidney Blood Press Res. 2011;35:129–34. Páll D, Kiss I, Katona É. Importance of ambulatory blood pressure monitoring. Kidney Blood Press Res. 2011;35:129–34.
32.
Zurück zum Zitat Varis J, Savola H, Vesalainen R, Kantola I. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines. Blood Press. 2009;18:62–7.PubMedCrossRef Varis J, Savola H, Vesalainen R, Kantola I. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines. Blood Press. 2009;18:62–7.PubMedCrossRef
33.
Zurück zum Zitat Rayner B, Schoeman HS. A cross-sectional study of blood pressure control in hypertensive patients in general practice (the I-TARGET study). Cardiovasc J Afr. 2009;20:224–7.PubMed Rayner B, Schoeman HS. A cross-sectional study of blood pressure control in hypertensive patients in general practice (the I-TARGET study). Cardiovasc J Afr. 2009;20:224–7.PubMed
34.
Zurück zum Zitat Filipi A, Casula M, Tragni E, Brignoli O, Cricelli C, Poli A, Catapano AL, CHECK Study group. Blood pressure and antihypertensive therapy according to the global cardiovascular risk level in Italy; the CHECK Study. Eur J Cardiovasc Prev Rehabil. 2010;17:562–8.CrossRef Filipi A, Casula M, Tragni E, Brignoli O, Cricelli C, Poli A, Catapano AL, CHECK Study group. Blood pressure and antihypertensive therapy according to the global cardiovascular risk level in Italy; the CHECK Study. Eur J Cardiovasc Prev Rehabil. 2010;17:562–8.CrossRef
35.
Zurück zum Zitat Lüders S, Schrader J, Schmieder RE, Smolka W, Wegscheider K, Bestehorn K. Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil. 2010;17:271–9.PubMed Lüders S, Schrader J, Schmieder RE, Smolka W, Wegscheider K, Bestehorn K. Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil. 2010;17:271–9.PubMed
36.
Zurück zum Zitat Orozco-Beltrán D, Gil-Guillen VF, Quirce F, Navarro-Perez J, Pineda M, Gomez-de-la-Cámara A, Pita S, Diez-Espino J, Mateos J, Merino J, Serrano-Rios M. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain. Collaborative Diabetes Study Investigators. Int J Clin Pract. 2007 Jun;61(6):909–15.PubMedCrossRef Orozco-Beltrán D, Gil-Guillen VF, Quirce F, Navarro-Perez J, Pineda M, Gomez-de-la-Cámara A, Pita S, Diez-Espino J, Mateos J, Merino J, Serrano-Rios M. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain. Collaborative Diabetes Study Investigators. Int J Clin Pract. 2007 Jun;61(6):909–15.PubMedCrossRef
37.
Zurück zum Zitat Prévost G, Phan TM, Mounier-Vehier C, Fontaine P. Control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in a French national study (Phenomen). Diabetes Metab. 2005;31:479–85.PubMedCrossRef Prévost G, Phan TM, Mounier-Vehier C, Fontaine P. Control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in a French national study (Phenomen). Diabetes Metab. 2005;31:479–85.PubMedCrossRef
38.
Zurück zum Zitat Váller H, Reibis R, Pittrow D, Jannowitz C, Wegscheider K, Karmann B, Bestehorn K. Secondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainment. Curr Med Res Opin. 2009;25:879–90.CrossRef Váller H, Reibis R, Pittrow D, Jannowitz C, Wegscheider K, Karmann B, Bestehorn K. Secondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainment. Curr Med Res Opin. 2009;25:879–90.CrossRef
39.
Zurück zum Zitat Marcelino M, Nobre EL, Chambel P, Domingues A, da Silva MP, Santos V, Vilar H, Oliviera Lopes L, Carvalho R, Santana Lopes M, Paradinha M, Jacome De Castro J. Quality of care in diabetic outpatient clinics. (in Portugal). Acta Med Port. 2010;23:904–14. Marcelino M, Nobre EL, Chambel P, Domingues A, da Silva MP, Santos V, Vilar H, Oliviera Lopes L, Carvalho R, Santana Lopes M, Paradinha M, Jacome De Castro J. Quality of care in diabetic outpatient clinics. (in Portugal). Acta Med Port. 2010;23:904–14.
40.
Zurück zum Zitat Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR. Hypertension treatment and control in five European countries, Canada and the United States. Hypertension. 2004;43:10–7. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR. Hypertension treatment and control in five European countries, Canada and the United States. Hypertension. 2004;43:10–7.
41.
Zurück zum Zitat Primatesta P, Poulter N. Hypertension management and control among English adults aged 65 years and older in 2000 and 2001. J Hypertens. 2004;22:1093–8.PubMedCrossRef Primatesta P, Poulter N. Hypertension management and control among English adults aged 65 years and older in 2000 and 2001. J Hypertens. 2004;22:1093–8.PubMedCrossRef
42.
Zurück zum Zitat Van Ganse E, Laforest L, Alemao E, Davies G, Gutkin S, Yin D. Lipid modifying therapy and attainment of cholesterol goals in Europe: the return on expenditure achieved for lipid therapy (REALITY) study. Curr Med Res Opinion. 2005;21:1389–99.CrossRef Van Ganse E, Laforest L, Alemao E, Davies G, Gutkin S, Yin D. Lipid modifying therapy and attainment of cholesterol goals in Europe: the return on expenditure achieved for lipid therapy (REALITY) study. Curr Med Res Opinion. 2005;21:1389–99.CrossRef
43.
Zurück zum Zitat Alzahrani T, Marrat S, Haider A. Management of dyslipidaemia in primary care. Can J Cardiol. 2003;19:1499–502.PubMed Alzahrani T, Marrat S, Haider A. Management of dyslipidaemia in primary care. Can J Cardiol. 2003;19:1499–502.PubMed
44.
Zurück zum Zitat Ghandehary H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidaemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003–2004. Am Heart J. 2008;156:112–9.CrossRef Ghandehary H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidaemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003–2004. Am Heart J. 2008;156:112–9.CrossRef
45.
Zurück zum Zitat Hobbs R, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract. 2002;19:596–604.PubMedCrossRef Hobbs R, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract. 2002;19:596–604.PubMedCrossRef
46.
Zurück zum Zitat Fleetcroft R, Steel N, Cookson R, Howe A. “Mind the gap!” Evaluation of the performance gap attributable to exception reporting and target thresholds in the new GMS contract: national database analysis. BMC Health Serv Res. 2008;8:131.PubMedCrossRef Fleetcroft R, Steel N, Cookson R, Howe A. “Mind the gap!” Evaluation of the performance gap attributable to exception reporting and target thresholds in the new GMS contract: national database analysis. BMC Health Serv Res. 2008;8:131.PubMedCrossRef
47.
Zurück zum Zitat Malocco E, Ferri C, Grandi AM, Kilama MO, Soglian AG, Vigna L. Treatment of hypertension and adherence to treatment guidelines in clinical practice: an Italian study. Adv Ther. 2005;22:96–106.CrossRef Malocco E, Ferri C, Grandi AM, Kilama MO, Soglian AG, Vigna L. Treatment of hypertension and adherence to treatment guidelines in clinical practice: an Italian study. Adv Ther. 2005;22:96–106.CrossRef
48.
Zurück zum Zitat McElduff P, Jaefarnezhad M, Durrington PN. American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively. Heart. 2006;92:1213–8.PubMedCrossRef McElduff P, Jaefarnezhad M, Durrington PN. American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively. Heart. 2006;92:1213–8.PubMedCrossRef
49.
Zurück zum Zitat Flamm M, Panisch S, Winkler H, Johansson T, Weitgasser R, Sönnichsen AC. Effectiveness of the Austrian disease management programme “Therapie Aktiv” for type 2 diabetes regarding the improvement of metabolic control, risk profile and guideline adherence: 2 years of follow up. Wiener Klin Woch. 2012;124:639–46.CrossRef Flamm M, Panisch S, Winkler H, Johansson T, Weitgasser R, Sönnichsen AC. Effectiveness of the Austrian disease management programme “Therapie Aktiv” for type 2 diabetes regarding the improvement of metabolic control, risk profile and guideline adherence: 2 years of follow up. Wiener Klin Woch. 2012;124:639–46.CrossRef
50.
Zurück zum Zitat Lalders SJ, Schmieder RE, Smolka W, Wegscheider K, Bestehorn K. Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil. 2010;17:271–9. Lalders SJ, Schmieder RE, Smolka W, Wegscheider K, Bestehorn K. Improvement of hypertension management by structured physician education and feedback system: cluster randomized trial. Eur J Cardiovasc Prev Rehabil. 2010;17:271–9.
Metadaten
Titel
Primary care of patients with high cardiovascular risk
Blood pressure, lipid and diabetic target levels and their achievement in Hungary
verfasst von
Endre Szigethy, MSc
Zoltán Jancsó
Csaba Móczár
István Ilyés
Eszter Kovács
László Róbert Kolozsvári
Imre Rurik, PhD, MSc
Publikationsdatum
01.07.2013
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 13-14/2013
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-013-0379-2

Weitere Artikel der Ausgabe 13-14/2013

Wiener klinische Wochenschrift 13-14/2013 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in wien

Preisverleihung

mitteilungen der gesellschaft

Knochen- und Mineralstoffwechsel